Literature DB >> 4033667

Binding and structural diversity among high-affinity monoclonal anti-digoxin antibodies.

M Mudgett-Hunter, W Anderson, E Haber, M N Margolies.   

Abstract

High-affinity monoclonal antibodies specific for the cardiac glycoside digoxin provide a useful system for the study of structure-function relationships between antibody combining site and specific antigenic determinants. Fifteen high-affinity monoclonal anti-digoxin antibodies were produced when spleen cells from A/J mice immunized with digoxin coupled to human serum albumin (Dig-HSA) were fused with the non-secreting murine myeloma Sp2/0 cell line. Each subcloned hybridoma antibody was analyzed for affinity and specificity for structurally related cardiac glycosides by a radioimmunoassay based on the adsorption of free [3H]digoxin to dextran-coated charcoal. All of the anti-digoxin hybridoma proteins demonstrated high affinity constants ranging from 10(9) to 10(12) M-1. Using seven different analogs of digoxin, binding specificities of the monoclonal antibodies were assessed by inhibition radioimmunoassay. The 15 hybridomas produced from fusions involving five mice could be divided into eight sets on the basis of these binding specificities. Certain antibodies exhibit a preference for the aglycone portion of digoxin, while others are more specific for the tridigitoxose sugar moiety of digoxin. Monoclonal antibody H- and L-chains were subjected to N-terminal amino acid sequence analysis. The antibodies may be divided into several sequence homology sets for both H- and L-chains. In most instances, homologous heavy chains are associated with a set of homologous light chains. Homologous partial sequences, however, do not correlate with similar antigenic specificities and affinities for digoxin. Thus the fine specificity for antigen is not dependent on VH- and VL-encoded sequences alone. These data illustrate the broad diversity of the elicited response to a single hapten, even in inbred mice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4033667     DOI: 10.1016/0161-5890(85)90132-4

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  14 in total

Review 1.  Monoclonal antibodies in hapten immunoassays.

Authors:  O N Chappey; P Sandouk; J M Scherrmann
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

2.  Nucleotide sequences and three-dimensional modelling of the VH and VL domains of two human monoclonal antibodies specific for the D antigen of the human Rh-blood-group system.

Authors:  N C Hughes-Jones; J M Bye; D Beale; J Coadwell
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

3.  The endogenous Mtv-8 provirus resides within the V kappa locus.

Authors:  J N Yang; J P Dudley
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo.

Authors:  M S Runge; C Bode; G R Matsueda; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Sequence, specificity and crystallization of an oestrone-3-glucuronide antibody (3910).

Authors:  M He; M Gani; O Livnah; E A Stura; D Beale; J Coley; I A Wilson; M J Taussig
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

6.  Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin.

Authors:  G L Reed; G R Matsueda; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  On the structure of endogenous ouabain.

Authors:  A Kawamura; J Guo; Y Itagaki; C Bell; Y Wang; G T Haupert; S Magil; R T Gallagher; N Berova; K Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

8.  Human monoclonal antibodies with different fine specificity for digoxin derivatives: cloning of heavy and light chain variable region sequences.

Authors:  L Danielsson; C Furebring; M Ohlin; L Hultman; M Abrahamson; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

9.  26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity.

Authors:  P D Jeffrey; R K Strong; L C Sieker; C Y Chang; R L Campbell; G A Petsko; E Haber; M N Margolies; S Sheriff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Anti-digoxin Fab variants generated by phage display.

Authors:  Viviane Midori Murata; Mariana Costa Braga Schmidt; Jorge Kalil; Lilian Rumi Tsuruta; Ana Maria Moro
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.